Jonathan C. Roberts - 01 Apr 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP & Chief Operating Officer
Signature
Jonathan C. Roberts
Issuer symbol
CVS
Transactions as of
01 Apr 2022
Net transactions value
+$2,627,026
Form type
4
Filing time
05 Apr 2022, 17:43:33 UTC
Previous filing
23 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CVS Common Stock 426,025 01 Apr 2022 Direct
holding CVS Common Stock 38,192 01 Apr 2022 By GRAT
holding CVS Common Stock (restricted) 12,812 01 Apr 2022 Direct
holding CVS ESOP Common Stock 6,156 01 Apr 2022 By ESOP
holding CVS Stock Unit 341,392 01 Apr 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Award $2,627,026 +25,987 $101.09 25,987 01 Apr 2022 Common Stock 25,987 $101.09 Direct F1
holding CVS Phantom Stock Credits 1,416 01 Apr 2022 Common Stock 1,416 $1.00 Direct F2
holding CVS Stock Option 161,318 01 Apr 2022 Common Stock 161,318 $104.82 Direct F3
holding CVS Stock Option 200,358 01 Apr 2022 Common Stock 200,358 $78.05 Direct F4
holding CVS Stock Option 248,131 01 Apr 2022 Common Stock 248,131 $62.21 Direct F5
holding CVS Stock Option 303,010 01 Apr 2022 Common Stock 303,010 $54.19 Direct F6
holding CVS Stock Option 239,355 01 Apr 2022 Common Stock 239,355 $58.34 Direct F7, F8
holding CVS Stock Option 172,772 01 Apr 2022 Common Stock 172,772 $74.30 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option becomes exercisable in four equal installments, commencing 4/1/2023.
F2 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F3 Option became exercisable in four equal annual installments, commencing 4/1/2017.
F4 Option became exercisable in four equal annual installments, commencing 4/3/2018.
F5 Option became exercisable in four equal annual installments, commencing 4/1/2019.
F6 Option became exercisable in four equal annual installments, commencing 4/1/2020.
F7 The number of shares subject to the option were calculated using a 30-day average price.
F8 Options became exercisable in four equal installments, commencing 4/1/2021.
F9 Option becomes exercisable in four equal installments, commencing 4/1/2022.